Advertisement
Screener

QT IMAGING HOLDINGS, INC. (QTI) Financing Cash Flow

2.8 / 5 stars · 68/120 Roast Me

QT IMAGING HOLDINGS, INC. Financing Cash Flow

QT IMAGING HOLDINGS, INC. (QTI) reported Financing Cash Flow of $9.19 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-12

  • QT IMAGING HOLDINGS, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $9.04M, a 1624.24% increase year-over-year.
  • QT IMAGING HOLDINGS, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $159.00K, a 97.03% decline year-over-year.
  • QT IMAGING HOLDINGS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $11.91M, a 1211.84% increase year-over-year.
  • QT IMAGING HOLDINGS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $571.69K.
  • QT IMAGING HOLDINGS, INC. net cash provided by (used in) financing activities for fiscal 2025 was $18.35M, a 64.93% increase from fiscal 2024.
  • QT IMAGING HOLDINGS, INC. net cash provided by (used in) financing activities for fiscal 2024 was $11.13M, a 368.79% increase from fiscal 2023.
  • QT IMAGING HOLDINGS, INC. net cash provided by (used in) financing activities for fiscal 2023 was $2.37M.
  • QT IMAGING HOLDINGS, INC. net cash provided by (used in) financing activities for fiscal 2022 was -$191.32M.
Period endNet Cash Provided by (Used in) Financing Activities 2 monthNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 3 month as first filedNet Cash Provided by (Used in) Financing Activities 5 monthNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 6 month as first filedNet Cash Provided by (Used in) Financing Activities 8 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 9 month as first filedNet Cash Provided by (Used in) Financing Activities 11 monthNet Cash Provided by (Used in) Financing Activities 12 monthNet Cash Provided by (Used in) Financing Activities 12 month as first filed
2026-06-30$9.04M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
$9.19M
10-Q · filed 2026-08-12
$21.10M
derived: sum of 3 quarters · filed 2026-08-12
$21.67M
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31$159.00K
10-Q · filed 2026-05-13
$12.06M
derived: sum of 2 quarters · filed 2026-05-13
$12.64M
derived: sum of 3 quarters · filed 2026-05-13
$13.16M
derived: sum of 4 quarters · filed 2026-08-12
2025-12-31$11.91M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
$12.48M
derived: sum of 2 quarters · filed 2026-03-25
$13.00M
derived: sum of 3 quarters · filed 2026-08-12
$18.35M
10-K · filed 2026-03-25
2025-09-30$571.69K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$1.10M
derived: sum of 2 quarters · filed 2026-08-12
$6.45M
10-Q · filed 2025-11-12
$7.36M
derived: sum of 4 quarters · filed 2026-08-12
2025-06-30$524.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
$5.88M
10-Q · filed 2026-08-12
$5.88M
10-Q · filed 2025-08-07
$6.78M
derived: sum of 3 quarters · filed 2026-08-12
$5.61M
derived: sum of 4 quarters · filed 2026-08-12
2025-03-31$5.35M
10-Q · filed 2026-05-13
$5.35M
10-Q · filed 2025-05-13
$6.26M
derived: sum of 2 quarters · filed 2026-05-13
$5.08M
derived: sum of 3 quarters · filed 2026-05-13
$5.05M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31$907.52K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
-$270.51K
derived: sum of 2 quarters · filed 2026-03-25
-$303.06K
derived: sum of 3 quarters · filed 2026-03-25
$11.13M
10-K · filed 2026-03-25
$11.13M
10-K · filed 2025-03-31
2024-09-30-$1.18M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
-$1.21M
derived: sum of 2 quarters · filed 2025-11-12
$10.22M
10-Q · filed 2025-11-12
$11.02M
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30-$32.55K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$11.40M
10-Q · filed 2025-08-07
$12.20M
derived: sum of 3 quarters · filed 2025-08-07
$12.47M
derived: sum of 4 quarters · filed 2025-08-07
2024-03-31$11.43M
10-Q · filed 2025-05-13
$12.23M
derived: sum of 2 quarters · filed 2025-05-13
$12.50M
derived: sum of 3 quarters · filed 2025-05-13
$12.89M
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31$802.61K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
$1.07M
derived: sum of 2 quarters · filed 2025-03-31
$1.46M
derived: sum of 3 quarters · filed 2025-03-31
$2.37M
10-K · filed 2025-03-31
-$18.05M
10-K · filed 2024-03-25
2023-09-30$267.70K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13
$655.48K
derived: sum of 2 quarters · filed 2024-11-13
$1.57M
10-Q · filed 2024-11-13
-$18.55M
10-Q · filed 2023-11-14
$2.25M
derived: sum of 4 quarters · filed 2024-11-13
2023-06-30$387.78K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
$1.30M
10-Q · filed 2024-08-08
-$8.99M
10-Q · filed 2023-08-14
$1.98M
derived: sum of 3 quarters · filed 2024-08-08
2023-03-31$915.70K
10-Q · filed 2024-05-13
-$9.48M
10-Q · filed 2023-05-15
$1.59M
derived: sum of 2 quarters · filed 2024-05-13
2022-12-31$675.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25
-$191.32M
10-K · filed 2024-03-25
2022-09-30-$192.00M
10-Q · filed 2023-11-14
2021-12-31$234.09M
10-K · filed 2023-03-31
2021-09-30$234.38M
10-Q · filed 2022-11-14
2021-06-30$45.21K
10-Q · filed 2022-08-15
2021-03-31$45.21K
10-Q · filed 2022-05-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
Outset Medical, Inc. (OM)United States$0.059B-1.09
IRIDEX CORP (IRIX)United States$0.011B
ENDRA Life Sciences Inc. (NDRA)United States$0.009B
Nuwellis, Inc. (NUWE)United States$0.003B
Streamex Corp. (STEX)United States$0.089B-0.19
Nexalin Technology, Inc. (NXL)United States$0.094B
Neuraxis, INC (NRXS)United States$0.097B
electroCore, Inc. (ECOR)United States$0.102B
Vivani Medical, Inc. (VANI)United States$0.111B